Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00290706
Status:
TERMINATED
Last Update Posted:
2019-05-28
First Post:
2006-02-09
Brief Title:
A Phase III Trial of VELCADE Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkins Lymphoma
Sponsor:
Northwestern University
Organization:
Northwestern University
Organization Data
Organization:
Northwestern University
Class:
OTHER
Study ID:
NU 04H4
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Northwestern University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Millennium Pharmaceuticals Inc | INDUSTRY |
| Eli Lilly and Company | INDUSTRY |